nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—Pentoxifylline—systemic scleroderma	0.366	1	CrCtD
Caffeine—migraine—Prednisone—systemic scleroderma	0.155	1	CpDpCtD
Caffeine—Theobromine—Pentoxifylline—systemic scleroderma	0.0811	0.366	CrCrCtD
Caffeine—Fenethylline—Pentoxifylline—systemic scleroderma	0.0701	0.317	CrCrCtD
Caffeine—Dyphylline—Pentoxifylline—systemic scleroderma	0.0701	0.317	CrCrCtD
Caffeine—ADORA2B—Pentoxifylline—systemic scleroderma	0.0519	0.278	CbGbCtD
Caffeine—ADORA1—Pentoxifylline—systemic scleroderma	0.0375	0.201	CbGbCtD
Caffeine—ADORA2A—Pentoxifylline—systemic scleroderma	0.0332	0.178	CbGbCtD
Caffeine—PDE4B—Pentoxifylline—systemic scleroderma	0.0284	0.152	CbGbCtD
Caffeine—CYP2C8—Mometasone—systemic scleroderma	0.00676	0.0362	CbGbCtD
Caffeine—CYP1A2—Pentoxifylline—systemic scleroderma	0.00354	0.0189	CbGbCtD
Caffeine—CYP1A2—Leflunomide—systemic scleroderma	0.00337	0.0181	CbGbCtD
Caffeine—ABCB1—Lisinopril—systemic scleroderma	0.00309	0.0165	CbGbCtD
Caffeine—CYP2C9—Leflunomide—systemic scleroderma	0.00304	0.0163	CbGbCtD
Caffeine—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0028	0.015	CbGbCtD
Caffeine—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.00269	0.0144	CbGbCtD
Caffeine—ABCB1—Captopril—systemic scleroderma	0.00231	0.0124	CbGbCtD
Caffeine—CYP2D6—Captopril—systemic scleroderma	0.00218	0.0117	CbGbCtD
Caffeine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.00182	0.00975	CbGbCtD
Caffeine—CYP2C9—cardial valve—systemic scleroderma	0.00164	0.0704	CbGeAlD
Caffeine—ABCB1—Prednisone—systemic scleroderma	0.00146	0.0078	CbGbCtD
Caffeine—PIK3CD—artery—systemic scleroderma	0.00125	0.0537	CbGeAlD
Caffeine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00584	CbGbCtD
Caffeine—PIK3CB—artery—systemic scleroderma	0.00109	0.0468	CbGeAlD
Caffeine—PIK3CA—artery—systemic scleroderma	0.00108	0.0464	CbGeAlD
Caffeine—PIK3CD—endothelium—systemic scleroderma	0.00105	0.0454	CbGeAlD
Caffeine—PIK3CD—blood vessel—systemic scleroderma	0.000973	0.0418	CbGeAlD
Caffeine—PIK3CB—endothelium—systemic scleroderma	0.00092	0.0396	CbGeAlD
Caffeine—PIK3CA—endothelium—systemic scleroderma	0.000911	0.0392	CbGeAlD
Caffeine—CYP3A4—Prednisone—systemic scleroderma	0.000873	0.00467	CbGbCtD
Caffeine—PIK3CB—blood vessel—systemic scleroderma	0.000849	0.0365	CbGeAlD
Caffeine—PIK3CA—blood vessel—systemic scleroderma	0.00084	0.0361	CbGeAlD
Caffeine—ABCB1—Methotrexate—systemic scleroderma	0.000731	0.00391	CbGbCtD
Caffeine—Impaired healing—Mometasone—systemic scleroderma	0.000691	0.0333	CcSEcCtD
Caffeine—ATM—connective tissue—systemic scleroderma	0.000562	0.0242	CbGeAlD
Caffeine—ATM—skin of body—systemic scleroderma	0.000508	0.0218	CbGeAlD
Caffeine—PIK3CD—connective tissue—systemic scleroderma	0.000499	0.0215	CbGeAlD
Caffeine—PRKDC—smooth muscle tissue—systemic scleroderma	0.000487	0.0209	CbGeAlD
Caffeine—Impaired healing—Mycophenolic acid—systemic scleroderma	0.000477	0.023	CcSEcCtD
Caffeine—Acidosis—Captopril—systemic scleroderma	0.000474	0.0229	CcSEcCtD
Caffeine—PIK3CD—smooth muscle tissue—systemic scleroderma	0.000456	0.0196	CbGeAlD
Caffeine—PIK3CD—skin of body—systemic scleroderma	0.00045	0.0194	CbGeAlD
Caffeine—PIK3CB—connective tissue—systemic scleroderma	0.000435	0.0187	CbGeAlD
Caffeine—PIK3CA—connective tissue—systemic scleroderma	0.000431	0.0185	CbGeAlD
Caffeine—ATM—digestive system—systemic scleroderma	0.000406	0.0175	CbGeAlD
Caffeine—PIK3CB—smooth muscle tissue—systemic scleroderma	0.000398	0.0171	CbGeAlD
Caffeine—RYR1—smooth muscle tissue—systemic scleroderma	0.000394	0.0169	CbGeAlD
Caffeine—PIK3CA—smooth muscle tissue—systemic scleroderma	0.000394	0.0169	CbGeAlD
Caffeine—PIK3CB—skin of body—systemic scleroderma	0.000393	0.0169	CbGeAlD
Caffeine—PIK3CA—skin of body—systemic scleroderma	0.000389	0.0167	CbGeAlD
Caffeine—Impaired healing—Mycophenolate mofetil—systemic scleroderma	0.000377	0.0182	CcSEcCtD
Caffeine—Acidosis—Mycophenolic acid—systemic scleroderma	0.000373	0.018	CcSEcCtD
Caffeine—PRKDC—tendon—systemic scleroderma	0.000366	0.0157	CbGeAlD
Caffeine—PIK3CD—digestive system—systemic scleroderma	0.00036	0.0155	CbGeAlD
Caffeine—ATM—lung—systemic scleroderma	0.000339	0.0146	CbGeAlD
Caffeine—PRKDC—Danazol—Prednisone—systemic scleroderma	0.000326	1	CbGdCrCtD
Caffeine—PRKDC—lung—systemic scleroderma	0.000321	0.0138	CbGeAlD
Caffeine—PIK3CB—digestive system—systemic scleroderma	0.000314	0.0135	CbGeAlD
Caffeine—PIK3CA—digestive system—systemic scleroderma	0.000311	0.0134	CbGeAlD
Caffeine—PIK3CD—lung—systemic scleroderma	0.000301	0.0129	CbGeAlD
Caffeine—PIK3CB—tendon—systemic scleroderma	0.000299	0.0129	CbGeAlD
Caffeine—Hypercalcaemia—Mycophenolic acid—systemic scleroderma	0.000297	0.0143	CcSEcCtD
Caffeine—RYR1—tendon—systemic scleroderma	0.000296	0.0127	CbGeAlD
Caffeine—PIK3CA—tendon—systemic scleroderma	0.000296	0.0127	CbGeAlD
Caffeine—Acidosis—Mycophenolate mofetil—systemic scleroderma	0.000294	0.0142	CcSEcCtD
Caffeine—ADORA2B—smooth muscle tissue—systemic scleroderma	0.00029	0.0125	CbGeAlD
Caffeine—PIK3CB—lung—systemic scleroderma	0.000262	0.0113	CbGeAlD
Caffeine—PIK3CA—lung—systemic scleroderma	0.00026	0.0112	CbGeAlD
Caffeine—Impaired healing—Prednisone—systemic scleroderma	0.000255	0.0123	CcSEcCtD
Caffeine—Urine output increased—Captopril—systemic scleroderma	0.000237	0.0114	CcSEcCtD
Caffeine—Injury—Mometasone—systemic scleroderma	0.000236	0.0114	CcSEcCtD
Caffeine—Hypercalcaemia—Mycophenolate mofetil—systemic scleroderma	0.000235	0.0113	CcSEcCtD
Caffeine—Accidental injury—Mycophenolic acid—systemic scleroderma	0.000233	0.0113	CcSEcCtD
Caffeine—Creatinine increased—Mycophenolic acid—systemic scleroderma	0.000217	0.0105	CcSEcCtD
Caffeine—Impaired healing—Methotrexate—systemic scleroderma	0.000213	0.0103	CcSEcCtD
Caffeine—Accidental injury—Lisinopril—systemic scleroderma	0.00021	0.0101	CcSEcCtD
Caffeine—Creatinine increased—Lisinopril—systemic scleroderma	0.000195	0.00942	CcSEcCtD
Caffeine—Infestation—Pentoxifylline—systemic scleroderma	0.000194	0.00935	CcSEcCtD
Caffeine—Infestation NOS—Pentoxifylline—systemic scleroderma	0.000194	0.00935	CcSEcCtD
Caffeine—ADORA2B—lung—systemic scleroderma	0.000191	0.00822	CbGeAlD
Caffeine—Sepsis—Leflunomide—systemic scleroderma	0.000188	0.00906	CcSEcCtD
Caffeine—Accidental injury—Mycophenolate mofetil—systemic scleroderma	0.000184	0.00888	CcSEcCtD
Caffeine—Pulmonary oedema—Mycophenolic acid—systemic scleroderma	0.000184	0.00886	CcSEcCtD
Caffeine—Sepsis—Mycophenolic acid—systemic scleroderma	0.000179	0.00864	CcSEcCtD
Caffeine—Haemoglobin—Pentoxifylline—systemic scleroderma	0.000175	0.00843	CcSEcCtD
Caffeine—Haemorrhage—Pentoxifylline—systemic scleroderma	0.000174	0.00839	CcSEcCtD
Caffeine—Creatinine increased—Mycophenolate mofetil—systemic scleroderma	0.000171	0.00825	CcSEcCtD
Caffeine—Deafness—Mycophenolic acid—systemic scleroderma	0.000168	0.00808	CcSEcCtD
Caffeine—Pulmonary oedema—Lisinopril—systemic scleroderma	0.000166	0.00798	CcSEcCtD
Caffeine—Injury—Mycophenolic acid—systemic scleroderma	0.000163	0.00786	CcSEcCtD
Caffeine—Immune system disorder—Pentoxifylline—systemic scleroderma	0.000157	0.00758	CcSEcCtD
Caffeine—ADORA1—tendon—systemic scleroderma	0.000156	0.00673	CbGeAlD
Caffeine—Hypoglycaemia—Mycophenolic acid—systemic scleroderma	0.000154	0.00741	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Mycophenolic acid—systemic scleroderma	0.00015	0.00723	CcSEcCtD
Caffeine—Nervousness—Pentoxifylline—systemic scleroderma	0.000147	0.00709	CcSEcCtD
Caffeine—Injury—Lisinopril—systemic scleroderma	0.000147	0.00708	CcSEcCtD
Caffeine—Pulmonary oedema—Mycophenolate mofetil—systemic scleroderma	0.000145	0.00699	CcSEcCtD
Caffeine—Renal failure—Captopril—systemic scleroderma	0.000144	0.00696	CcSEcCtD
Caffeine—CYP1B1—connective tissue—systemic scleroderma	0.000144	0.0062	CbGeAlD
Caffeine—Dry skin—Leflunomide—systemic scleroderma	0.000144	0.00694	CcSEcCtD
Caffeine—Sepsis—Mycophenolate mofetil—systemic scleroderma	0.000141	0.00682	CcSEcCtD
Caffeine—Blood creatinine increased—Mycophenolic acid—systemic scleroderma	0.00014	0.00677	CcSEcCtD
Caffeine—Agitation—Pentoxifylline—systemic scleroderma	0.000139	0.00671	CcSEcCtD
Caffeine—Gastritis—Leflunomide—systemic scleroderma	0.000139	0.00671	CcSEcCtD
Caffeine—Hypoglycaemia—Lisinopril—systemic scleroderma	0.000138	0.00667	CcSEcCtD
Caffeine—ADORA1—lung—systemic scleroderma	0.000137	0.0059	CbGeAlD
Caffeine—Immune system disorder—Mometasone—systemic scleroderma	0.000136	0.00654	CcSEcCtD
Caffeine—Gastritis—Mycophenolic acid—systemic scleroderma	0.000133	0.0064	CcSEcCtD
Caffeine—Deafness—Mycophenolate mofetil—systemic scleroderma	0.000132	0.00638	CcSEcCtD
Caffeine—CYP1B1—smooth muscle tissue—systemic scleroderma	0.000132	0.00568	CbGeAlD
Caffeine—Convulsion—Pentoxifylline—systemic scleroderma	0.000131	0.00633	CcSEcCtD
Caffeine—Hypertension—Pentoxifylline—systemic scleroderma	0.000131	0.00631	CcSEcCtD
Caffeine—CYP1B1—skin of body—systemic scleroderma	0.00013	0.0056	CbGeAlD
Caffeine—Irritability—Lisinopril—systemic scleroderma	0.000129	0.00621	CcSEcCtD
Caffeine—Injury—Mycophenolate mofetil—systemic scleroderma	0.000129	0.00621	CcSEcCtD
Caffeine—Infestation NOS—Azathioprine—systemic scleroderma	0.000128	0.00618	CcSEcCtD
Caffeine—Infestation—Azathioprine—systemic scleroderma	0.000128	0.00618	CcSEcCtD
Caffeine—Blood creatinine increased—Lisinopril—systemic scleroderma	0.000126	0.0061	CcSEcCtD
Caffeine—Infection—Pentoxifylline—systemic scleroderma	0.000123	0.00592	CcSEcCtD
Caffeine—Hyperglycaemia—Leflunomide—systemic scleroderma	0.000122	0.00591	CcSEcCtD
Caffeine—Hypoglycaemia—Mycophenolate mofetil—systemic scleroderma	0.000121	0.00584	CcSEcCtD
Caffeine—Infestation—Leflunomide—systemic scleroderma	0.000121	0.00584	CcSEcCtD
Caffeine—Infestation NOS—Leflunomide—systemic scleroderma	0.000121	0.00584	CcSEcCtD
Caffeine—Tachycardia—Pentoxifylline—systemic scleroderma	0.000121	0.00582	CcSEcCtD
Caffeine—Skin disorder—Pentoxifylline—systemic scleroderma	0.00012	0.00579	CcSEcCtD
Caffeine—Gastritis—Lisinopril—systemic scleroderma	0.000119	0.00576	CcSEcCtD
Caffeine—Renal failure—Leflunomide—systemic scleroderma	0.000119	0.00574	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000118	0.0057	CcSEcCtD
Caffeine—Hyperglycaemia—Mycophenolic acid—systemic scleroderma	0.000117	0.00564	CcSEcCtD
Caffeine—PDE4B—tendon—systemic scleroderma	0.000116	0.00498	CbGeAlD
Caffeine—Haemoglobin—Azathioprine—systemic scleroderma	0.000116	0.00558	CcSEcCtD
Caffeine—Infestation NOS—Mycophenolic acid—systemic scleroderma	0.000115	0.00557	CcSEcCtD
Caffeine—Infestation—Mycophenolic acid—systemic scleroderma	0.000115	0.00557	CcSEcCtD
Caffeine—Haemorrhage—Azathioprine—systemic scleroderma	0.000115	0.00555	CcSEcCtD
Caffeine—Renal failure—Mycophenolic acid—systemic scleroderma	0.000114	0.00548	CcSEcCtD
Caffeine—Nervousness—Captopril—systemic scleroderma	0.000111	0.00538	CcSEcCtD
Caffeine—Blood creatinine increased—Mycophenolate mofetil—systemic scleroderma	0.000111	0.00534	CcSEcCtD
Caffeine—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00011	0.00532	CcSEcCtD
Caffeine—Haemoglobin—Leflunomide—systemic scleroderma	0.000109	0.00527	CcSEcCtD
Caffeine—Haemorrhage—Leflunomide—systemic scleroderma	0.000109	0.00524	CcSEcCtD
Caffeine—Infection—Mometasone—systemic scleroderma	0.000106	0.00511	CcSEcCtD
Caffeine—Hyperglycaemia—Lisinopril—systemic scleroderma	0.000105	0.00508	CcSEcCtD
Caffeine—Gastritis—Mycophenolate mofetil—systemic scleroderma	0.000105	0.00505	CcSEcCtD
Caffeine—CYP1B1—digestive system—systemic scleroderma	0.000104	0.00448	CbGeAlD
Caffeine—Haemoglobin—Mycophenolic acid—systemic scleroderma	0.000104	0.00503	CcSEcCtD
Caffeine—Immune system disorder—Azathioprine—systemic scleroderma	0.000104	0.00501	CcSEcCtD
Caffeine—Haemorrhage—Mycophenolic acid—systemic scleroderma	0.000104	0.005	CcSEcCtD
Caffeine—ABCB1—blood vessel—systemic scleroderma	0.000103	0.00444	CbGeAlD
Caffeine—Renal failure—Lisinopril—systemic scleroderma	0.000102	0.00493	CcSEcCtD
Caffeine—PDE4B—lung—systemic scleroderma	0.000102	0.00437	CbGeAlD
Caffeine—Cardiac disorder—Leflunomide—systemic scleroderma	0.000101	0.00486	CcSEcCtD
Caffeine—CYP1B1—tendon—systemic scleroderma	9.92e-05	0.00427	CbGeAlD
Caffeine—Pulmonary oedema—Prednisone—systemic scleroderma	9.83e-05	0.00474	CcSEcCtD
Caffeine—Immune system disorder—Leflunomide—systemic scleroderma	9.82e-05	0.00473	CcSEcCtD
Caffeine—Cardiac disorder—Mycophenolic acid—systemic scleroderma	9.62e-05	0.00464	CcSEcCtD
Caffeine—Sepsis—Prednisone—systemic scleroderma	9.58e-05	0.00462	CcSEcCtD
Caffeine—Dyspnoea—Mometasone—systemic scleroderma	9.51e-05	0.00459	CcSEcCtD
Caffeine—Malnutrition—Leflunomide—systemic scleroderma	9.46e-05	0.00456	CcSEcCtD
Caffeine—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	9.22e-05	0.00445	CcSEcCtD
Caffeine—CYP1A1—skin of body—systemic scleroderma	9.21e-05	0.00396	CbGeAlD
Caffeine—Tachycardia—Captopril—systemic scleroderma	9.14e-05	0.00441	CcSEcCtD
Caffeine—Infestation NOS—Mycophenolate mofetil—systemic scleroderma	9.11e-05	0.0044	CcSEcCtD
Caffeine—Infestation—Mycophenolate mofetil—systemic scleroderma	9.11e-05	0.0044	CcSEcCtD
Caffeine—Hypersensitivity—Pentoxifylline—systemic scleroderma	9.11e-05	0.00439	CcSEcCtD
Caffeine—Malnutrition—Mycophenolic acid—systemic scleroderma	9.03e-05	0.00435	CcSEcCtD
Caffeine—Renal failure—Mycophenolate mofetil—systemic scleroderma	8.96e-05	0.00432	CcSEcCtD
Caffeine—Nervousness—Mycophenolic acid—systemic scleroderma	8.77e-05	0.00423	CcSEcCtD
Caffeine—Injury—Prednisone—systemic scleroderma	8.72e-05	0.00421	CcSEcCtD
Caffeine—CYP1B1—lung—systemic scleroderma	8.7e-05	0.00374	CbGeAlD
Caffeine—Dyspnoea—Captopril—systemic scleroderma	8.35e-05	0.00403	CcSEcCtD
Caffeine—Urine output increased—Methotrexate—systemic scleroderma	8.35e-05	0.00402	CcSEcCtD
Caffeine—Agitation—Mycophenolic acid—systemic scleroderma	8.29e-05	0.004	CcSEcCtD
Caffeine—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	8.22e-05	0.00397	CcSEcCtD
Caffeine—Pulmonary oedema—Methotrexate—systemic scleroderma	8.22e-05	0.00396	CcSEcCtD
Caffeine—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	8.18e-05	0.00395	CcSEcCtD
Caffeine—Hypertension—Leflunomide—systemic scleroderma	8.17e-05	0.00394	CcSEcCtD
Caffeine—Malnutrition—Lisinopril—systemic scleroderma	8.13e-05	0.00392	CcSEcCtD
Caffeine—Infection—Azathioprine—systemic scleroderma	8.12e-05	0.00392	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	8.02e-05	0.00387	CcSEcCtD
Caffeine—Sepsis—Methotrexate—systemic scleroderma	8.01e-05	0.00386	CcSEcCtD
Caffeine—Skin disorder—Azathioprine—systemic scleroderma	7.94e-05	0.00383	CcSEcCtD
Caffeine—Nervousness—Lisinopril—systemic scleroderma	7.9e-05	0.00381	CcSEcCtD
Caffeine—Convulsion—Mycophenolic acid—systemic scleroderma	7.82e-05	0.00377	CcSEcCtD
Caffeine—Rash—Pentoxifylline—systemic scleroderma	7.79e-05	0.00376	CcSEcCtD
Caffeine—Hypertension—Mycophenolic acid—systemic scleroderma	7.79e-05	0.00376	CcSEcCtD
Caffeine—Dermatitis—Pentoxifylline—systemic scleroderma	7.79e-05	0.00376	CcSEcCtD
Caffeine—Infection—Leflunomide—systemic scleroderma	7.67e-05	0.0037	CcSEcCtD
Caffeine—Irritability—Prednisone—systemic scleroderma	7.65e-05	0.00369	CcSEcCtD
Caffeine—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	7.59e-05	0.00366	CcSEcCtD
Caffeine—Nervous system disorder—Leflunomide—systemic scleroderma	7.57e-05	0.00365	CcSEcCtD
Caffeine—Tachycardia—Leflunomide—systemic scleroderma	7.54e-05	0.00363	CcSEcCtD
Caffeine—Skin disorder—Leflunomide—systemic scleroderma	7.5e-05	0.00362	CcSEcCtD
Caffeine—CYP1A2—digestive system—systemic scleroderma	7.47e-05	0.00321	CbGeAlD
Caffeine—CYP1A1—digestive system—systemic scleroderma	7.37e-05	0.00317	CbGeAlD
Caffeine—Dry skin—Prednisone—systemic scleroderma	7.35e-05	0.00354	CcSEcCtD
Caffeine—Infection—Mycophenolic acid—systemic scleroderma	7.32e-05	0.00353	CcSEcCtD
Caffeine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	7.22e-05	0.00348	CcSEcCtD
Caffeine—CYP3A5—digestive system—systemic scleroderma	7.2e-05	0.0031	CbGeAlD
Caffeine—Tachycardia—Mycophenolic acid—systemic scleroderma	7.19e-05	0.00347	CcSEcCtD
Caffeine—Skin disorder—Mycophenolic acid—systemic scleroderma	7.15e-05	0.00345	CcSEcCtD
Caffeine—Malnutrition—Mycophenolate mofetil—systemic scleroderma	7.12e-05	0.00344	CcSEcCtD
Caffeine—CYP2C9—digestive system—systemic scleroderma	7.09e-05	0.00305	CbGeAlD
Caffeine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	7.06e-05	0.0034	CcSEcCtD
Caffeine—Nervousness—Mycophenolate mofetil—systemic scleroderma	6.92e-05	0.00334	CcSEcCtD
Caffeine—Dyspnoea—Leflunomide—systemic scleroderma	6.88e-05	0.00332	CcSEcCtD
Caffeine—Rash—Mometasone—systemic scleroderma	6.73e-05	0.00324	CcSEcCtD
Caffeine—Dermatitis—Mometasone—systemic scleroderma	6.72e-05	0.00324	CcSEcCtD
Caffeine—CYP2E1—digestive system—systemic scleroderma	6.72e-05	0.00289	CbGeAlD
Caffeine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	6.67e-05	0.00321	CcSEcCtD
Caffeine—Infection—Lisinopril—systemic scleroderma	6.59e-05	0.00318	CcSEcCtD
Caffeine—Dyspnoea—Mycophenolic acid—systemic scleroderma	6.57e-05	0.00317	CcSEcCtD
Caffeine—Agitation—Mycophenolate mofetil—systemic scleroderma	6.55e-05	0.00316	CcSEcCtD
Caffeine—Tachycardia—Lisinopril—systemic scleroderma	6.48e-05	0.00312	CcSEcCtD
Caffeine—Skin disorder—Lisinopril—systemic scleroderma	6.44e-05	0.00311	CcSEcCtD
Caffeine—Irritability—Methotrexate—systemic scleroderma	6.4e-05	0.00308	CcSEcCtD
Caffeine—CYP2E1—tendon—systemic scleroderma	6.39e-05	0.00275	CbGeAlD
Caffeine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	6.36e-05	0.00307	CcSEcCtD
Caffeine—Hyperglycaemia—Prednisone—systemic scleroderma	6.25e-05	0.00301	CcSEcCtD
Caffeine—CYP1A2—lung—systemic scleroderma	6.24e-05	0.00268	CbGeAlD
Caffeine—Convulsion—Mycophenolate mofetil—systemic scleroderma	6.17e-05	0.00298	CcSEcCtD
Caffeine—CYP1A1—lung—systemic scleroderma	6.15e-05	0.00265	CbGeAlD
Caffeine—Hypertension—Mycophenolate mofetil—systemic scleroderma	6.15e-05	0.00297	CcSEcCtD
Caffeine—Hypersensitivity—Azathioprine—systemic scleroderma	6.02e-05	0.00291	CcSEcCtD
Caffeine—CYP3A5—lung—systemic scleroderma	6.02e-05	0.00259	CbGeAlD
Caffeine—Dyspnoea—Lisinopril—systemic scleroderma	5.92e-05	0.00285	CcSEcCtD
Caffeine—Rash—Captopril—systemic scleroderma	5.91e-05	0.00285	CcSEcCtD
Caffeine—Dermatitis—Captopril—systemic scleroderma	5.9e-05	0.00285	CcSEcCtD
Caffeine—Infection—Mycophenolate mofetil—systemic scleroderma	5.78e-05	0.00279	CcSEcCtD
Caffeine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	5.73e-05	0.00276	CcSEcCtD
Caffeine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	5.7e-05	0.00275	CcSEcCtD
Caffeine—Hypersensitivity—Leflunomide—systemic scleroderma	5.69e-05	0.00274	CcSEcCtD
Caffeine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	5.67e-05	0.00274	CcSEcCtD
Caffeine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	5.65e-05	0.00272	CcSEcCtD
Caffeine—CYP2E1—lung—systemic scleroderma	5.61e-05	0.00241	CbGeAlD
Caffeine—Haemoglobin—Prednisone—systemic scleroderma	5.57e-05	0.00269	CcSEcCtD
Caffeine—Haemorrhage—Prednisone—systemic scleroderma	5.55e-05	0.00267	CcSEcCtD
Caffeine—CYP3A4—digestive system—systemic scleroderma	5.41e-05	0.00232	CbGeAlD
Caffeine—CYP2D6—digestive system—systemic scleroderma	5.32e-05	0.00229	CbGeAlD
Caffeine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	5.18e-05	0.0025	CcSEcCtD
Caffeine—Infestation NOS—Methotrexate—systemic scleroderma	5.16e-05	0.00249	CcSEcCtD
Caffeine—Infestation—Methotrexate—systemic scleroderma	5.16e-05	0.00249	CcSEcCtD
Caffeine—Rash—Azathioprine—systemic scleroderma	5.16e-05	0.00249	CcSEcCtD
Caffeine—Dermatitis—Azathioprine—systemic scleroderma	5.15e-05	0.00248	CcSEcCtD
Caffeine—Renal failure—Methotrexate—systemic scleroderma	5.08e-05	0.00245	CcSEcCtD
Caffeine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	5.02e-05	0.00242	CcSEcCtD
Caffeine—Immune system disorder—Prednisone—systemic scleroderma	5.01e-05	0.00242	CcSEcCtD
Caffeine—Hypersensitivity—Lisinopril—systemic scleroderma	4.89e-05	0.00236	CcSEcCtD
Caffeine—Rash—Leflunomide—systemic scleroderma	4.87e-05	0.00235	CcSEcCtD
Caffeine—Dermatitis—Leflunomide—systemic scleroderma	4.86e-05	0.00235	CcSEcCtD
Caffeine—Malnutrition—Prednisone—systemic scleroderma	4.83e-05	0.00233	CcSEcCtD
Caffeine—Haemoglobin—Methotrexate—systemic scleroderma	4.66e-05	0.00225	CcSEcCtD
Caffeine—Rash—Mycophenolic acid—systemic scleroderma	4.64e-05	0.00224	CcSEcCtD
Caffeine—Dermatitis—Mycophenolic acid—systemic scleroderma	4.64e-05	0.00224	CcSEcCtD
Caffeine—Haemorrhage—Methotrexate—systemic scleroderma	4.64e-05	0.00224	CcSEcCtD
Caffeine—Agitation—Prednisone—systemic scleroderma	4.44e-05	0.00214	CcSEcCtD
Caffeine—Cardiac disorder—Methotrexate—systemic scleroderma	4.3e-05	0.00207	CcSEcCtD
Caffeine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	4.28e-05	0.00207	CcSEcCtD
Caffeine—Immune system disorder—Methotrexate—systemic scleroderma	4.19e-05	0.00202	CcSEcCtD
Caffeine—Rash—Lisinopril—systemic scleroderma	4.18e-05	0.00202	CcSEcCtD
Caffeine—Convulsion—Prednisone—systemic scleroderma	4.18e-05	0.00202	CcSEcCtD
Caffeine—Dermatitis—Lisinopril—systemic scleroderma	4.18e-05	0.00202	CcSEcCtD
Caffeine—Hypertension—Prednisone—systemic scleroderma	4.17e-05	0.00201	CcSEcCtD
Caffeine—Malnutrition—Methotrexate—systemic scleroderma	4.04e-05	0.00195	CcSEcCtD
Caffeine—Infection—Prednisone—systemic scleroderma	3.91e-05	0.00189	CcSEcCtD
Caffeine—Nervous system disorder—Prednisone—systemic scleroderma	3.86e-05	0.00186	CcSEcCtD
Caffeine—Tachycardia—Prednisone—systemic scleroderma	3.85e-05	0.00185	CcSEcCtD
Caffeine—Skin disorder—Prednisone—systemic scleroderma	3.83e-05	0.00185	CcSEcCtD
Caffeine—ABCB1—digestive system—systemic scleroderma	3.83e-05	0.00165	CbGeAlD
Caffeine—Rash—Mycophenolate mofetil—systemic scleroderma	3.67e-05	0.00177	CcSEcCtD
Caffeine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	3.66e-05	0.00177	CcSEcCtD
Caffeine—Convulsion—Methotrexate—systemic scleroderma	3.5e-05	0.00169	CcSEcCtD
Caffeine—Infection—Methotrexate—systemic scleroderma	3.27e-05	0.00158	CcSEcCtD
Caffeine—Nervous system disorder—Methotrexate—systemic scleroderma	3.23e-05	0.00156	CcSEcCtD
Caffeine—Skin disorder—Methotrexate—systemic scleroderma	3.2e-05	0.00154	CcSEcCtD
Caffeine—ABCB1—lung—systemic scleroderma	3.2e-05	0.00137	CbGeAlD
Caffeine—Dyspnoea—Methotrexate—systemic scleroderma	2.94e-05	0.00142	CcSEcCtD
Caffeine—Hypersensitivity—Prednisone—systemic scleroderma	2.9e-05	0.0014	CcSEcCtD
Caffeine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	2.84e-05	0.00137	CcSEcCtD
Caffeine—Rash—Prednisone—systemic scleroderma	2.48e-05	0.0012	CcSEcCtD
Caffeine—Dermatitis—Prednisone—systemic scleroderma	2.48e-05	0.0012	CcSEcCtD
Caffeine—Hypersensitivity—Methotrexate—systemic scleroderma	2.43e-05	0.00117	CcSEcCtD
Caffeine—ADORA2B—GPCR ligand binding—EDN1—systemic scleroderma	2.1e-05	0.000797	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—CTLA4—systemic scleroderma	2.08e-05	0.00079	CbGpPWpGaD
Caffeine—Rash—Methotrexate—systemic scleroderma	2.08e-05	0.001	CcSEcCtD
Caffeine—Dermatitis—Methotrexate—systemic scleroderma	2.07e-05	0.001	CcSEcCtD
Caffeine—PIK3CA—DNA Damage Response (only ATM dependent)—TGFB1—systemic scleroderma	2.06e-05	0.00078	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—CSK—systemic scleroderma	2.04e-05	0.000772	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by SCF-KIT—MMP9—systemic scleroderma	2.03e-05	0.00077	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—BLK—systemic scleroderma	2.01e-05	0.00076	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—IRF5—systemic scleroderma	2e-05	0.000759	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—HLA-DQB1—systemic scleroderma	1.98e-05	0.000752	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—RHOB—systemic scleroderma	1.98e-05	0.00075	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—HLA-DQB1—systemic scleroderma	1.97e-05	0.000747	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—RHOB—systemic scleroderma	1.95e-05	0.000741	CbGpPWpGaD
Caffeine—PIK3CD—Disease—HSPG2—systemic scleroderma	1.95e-05	0.000738	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—ITGAM—systemic scleroderma	1.91e-05	0.000726	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—IRF8—systemic scleroderma	1.91e-05	0.000726	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—CD247—systemic scleroderma	1.91e-05	0.000726	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.9e-05	0.000722	CbGpPWpGaD
Caffeine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	1.9e-05	0.000719	CbGpPWpGaD
Caffeine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	1.89e-05	0.000715	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—IL1A—systemic scleroderma	1.88e-05	0.000714	CbGpPWpGaD
Caffeine—PIK3CD—Disease—CSK—systemic scleroderma	1.88e-05	0.000713	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—CD40LG—systemic scleroderma	1.87e-05	0.00071	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—SMAD7—systemic scleroderma	1.87e-05	0.000708	CbGpPWpGaD
Caffeine—PRKDC—Immune System—HLA-DQB1—systemic scleroderma	1.87e-05	0.000707	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—CD40LG—systemic scleroderma	1.86e-05	0.000705	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—RHOB—systemic scleroderma	1.85e-05	0.000702	CbGpPWpGaD
Caffeine—PIK3CA—Disease—SMAD7—systemic scleroderma	1.83e-05	0.000695	CbGpPWpGaD
Caffeine—PIK3CD—Hemostasis—MMP1—systemic scleroderma	1.83e-05	0.000694	CbGpPWpGaD
Caffeine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	1.81e-05	0.000687	CbGpPWpGaD
Caffeine—PIK3CD—Cytokine Signaling in Immune system—IL1B—systemic scleroderma	1.81e-05	0.000687	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—RHOB—systemic scleroderma	1.8e-05	0.000681	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—TNFAIP3—systemic scleroderma	1.79e-05	0.000679	CbGpPWpGaD
Caffeine—ADORA1—GPCR ligand binding—EDN1—systemic scleroderma	1.79e-05	0.000678	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—RHOB—systemic scleroderma	1.77e-05	0.000673	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—CSK—systemic scleroderma	1.77e-05	0.000673	CbGpPWpGaD
Caffeine—PRKDC—Immune System—IL1A—systemic scleroderma	1.77e-05	0.000672	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—BLK—systemic scleroderma	1.77e-05	0.000671	CbGpPWpGaD
Caffeine—PIK3CD—Disease—CD247—systemic scleroderma	1.77e-05	0.00067	CbGpPWpGaD
Caffeine—PRKDC—Immune System—CD40LG—systemic scleroderma	1.76e-05	0.000668	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—IRF5—systemic scleroderma	1.75e-05	0.000662	CbGpPWpGaD
Caffeine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—systemic scleroderma	1.72e-05	0.000652	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—HLA-DQB1—systemic scleroderma	1.72e-05	0.000651	CbGpPWpGaD
Caffeine—PIK3CD—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	1.7e-05	0.000645	CbGpPWpGaD
Caffeine—PIK3CB—Disease—HSPG2—systemic scleroderma	1.7e-05	0.000643	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—RHOB—systemic scleroderma	1.68e-05	0.000637	CbGpPWpGaD
Caffeine—PIK3CA—Disease—TGFBI—systemic scleroderma	1.68e-05	0.000635	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—CD247—systemic scleroderma	1.67e-05	0.000632	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—IRF8—systemic scleroderma	1.67e-05	0.000632	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—ITGAM—systemic scleroderma	1.67e-05	0.000632	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—CTLA4—systemic scleroderma	1.64e-05	0.000623	CbGpPWpGaD
Caffeine—PIK3CB—Disease—CSK—systemic scleroderma	1.64e-05	0.000621	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—HSPG2—systemic scleroderma	1.63e-05	0.000618	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—SMAD7—systemic scleroderma	1.63e-05	0.000617	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—CD40LG—systemic scleroderma	1.62e-05	0.000615	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—SMAD7—systemic scleroderma	1.61e-05	0.000612	CbGpPWpGaD
Caffeine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	1.6e-05	0.000608	CbGpPWpGaD
Caffeine—PIK3CB—Hemostasis—MMP1—systemic scleroderma	1.59e-05	0.000604	CbGpPWpGaD
Caffeine—PIK3CB—Cytokine Signaling in Immune system—IL1B—systemic scleroderma	1.58e-05	0.000599	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—TNFAIP3—systemic scleroderma	1.56e-05	0.000592	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—BLK—systemic scleroderma	1.54e-05	0.000585	CbGpPWpGaD
Caffeine—PIK3CB—Disease—CD247—systemic scleroderma	1.54e-05	0.000584	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—RHOB—systemic scleroderma	1.53e-05	0.000579	CbGpPWpGaD
Caffeine—PIK3CB—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	1.48e-05	0.000562	CbGpPWpGaD
Caffeine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	1.47e-05	0.000559	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	1.47e-05	0.000556	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—CTLA4—systemic scleroderma	1.45e-05	0.00055	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—RHOB—systemic scleroderma	1.44e-05	0.000548	CbGpPWpGaD
Caffeine—ADORA2B—GPCR ligand binding—CCL2—systemic scleroderma	1.44e-05	0.000545	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—HSPG2—systemic scleroderma	1.42e-05	0.000539	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CSK—systemic scleroderma	1.4e-05	0.00053	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—RHOB—systemic scleroderma	1.39e-05	0.000526	CbGpPWpGaD
Caffeine—ADORA2A—GPCR ligand binding—EDN1—systemic scleroderma	1.38e-05	0.000523	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IRF5—systemic scleroderma	1.38e-05	0.000522	CbGpPWpGaD
Caffeine—PIK3CD—GPCR downstream signaling—EDN1—systemic scleroderma	1.38e-05	0.000521	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—SMAD7—systemic scleroderma	1.37e-05	0.00052	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—HSPG2—systemic scleroderma	1.36e-05	0.000517	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—SMAD7—systemic scleroderma	1.36e-05	0.000514	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—HLA-DQB1—systemic scleroderma	1.35e-05	0.000513	CbGpPWpGaD
Caffeine—PIK3CA—Disease—HSPG2—systemic scleroderma	1.34e-05	0.000507	CbGpPWpGaD
Caffeine—PIK3CD—Hemostasis—NOS3—systemic scleroderma	1.33e-05	0.000503	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CSK—systemic scleroderma	1.32e-05	0.000499	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IRF8—systemic scleroderma	1.31e-05	0.000498	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—ITGAM—systemic scleroderma	1.31e-05	0.000498	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CD247—systemic scleroderma	1.31e-05	0.000498	CbGpPWpGaD
Caffeine—PIK3CA—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	1.31e-05	0.000498	CbGpPWpGaD
Caffeine—PIK3CA—Disease—CSK—systemic scleroderma	1.29e-05	0.000489	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—SMAD7—systemic scleroderma	1.28e-05	0.000486	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—CD40LG—systemic scleroderma	1.28e-05	0.000484	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—CTLA4—systemic scleroderma	1.26e-05	0.000479	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—RHOB—systemic scleroderma	1.26e-05	0.000478	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—MMP1—systemic scleroderma	1.26e-05	0.000476	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—EDN1—systemic scleroderma	1.25e-05	0.000474	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—RHOB—systemic scleroderma	1.25e-05	0.000473	CbGpPWpGaD
Caffeine—PIK3CA—Cytokine Signaling in Immune system—IL1B—systemic scleroderma	1.24e-05	0.000472	CbGpPWpGaD
Caffeine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	1.24e-05	0.00047	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—CTGF—systemic scleroderma	1.24e-05	0.000468	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—TNFAIP3—systemic scleroderma	1.23e-05	0.000467	CbGpPWpGaD
Caffeine—ADORA1—GPCR ligand binding—CCL2—systemic scleroderma	1.22e-05	0.000463	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—BLK—systemic scleroderma	1.22e-05	0.000461	CbGpPWpGaD
Caffeine—PIK3CA—Disease—CD247—systemic scleroderma	1.21e-05	0.00046	CbGpPWpGaD
Caffeine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	1.21e-05	0.000458	CbGpPWpGaD
Caffeine—PIK3CB—GPCR downstream signaling—EDN1—systemic scleroderma	1.2e-05	0.000455	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—HLA-DQB1—systemic scleroderma	1.19e-05	0.000453	CbGpPWpGaD
Caffeine—ADORA2B—GPCR downstream signaling—EDN1—systemic scleroderma	1.19e-05	0.00045	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—HSPG2—systemic scleroderma	1.19e-05	0.00045	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—HSPG2—systemic scleroderma	1.18e-05	0.000446	CbGpPWpGaD
Caffeine—PIK3CA—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	1.17e-05	0.000443	CbGpPWpGaD
Caffeine—PIK3CB—Hemostasis—NOS3—systemic scleroderma	1.16e-05	0.000438	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CSK—systemic scleroderma	1.15e-05	0.000435	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CSK—systemic scleroderma	1.14e-05	0.000431	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—IL1A—systemic scleroderma	1.13e-05	0.00043	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—CD40LG—systemic scleroderma	1.13e-05	0.000428	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—HSPG2—systemic scleroderma	1.12e-05	0.000424	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.11e-05	0.000421	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—EDN1—systemic scleroderma	1.09e-05	0.000413	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—EDN1—systemic scleroderma	1.08e-05	0.000409	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—CTGF—systemic scleroderma	1.08e-05	0.000408	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—RHOB—systemic scleroderma	1.06e-05	0.000402	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—SMAD7—systemic scleroderma	1.06e-05	0.000402	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—RHOB—systemic scleroderma	1.05e-05	0.000398	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—HLA-DQB1—systemic scleroderma	1.04e-05	0.000395	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—EDN1—systemic scleroderma	1.01e-05	0.000383	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—HSPG2—systemic scleroderma	1e-05	0.000379	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—EDN1—systemic scleroderma	9.98e-06	0.000378	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CTLA4—systemic scleroderma	9.96e-06	0.000378	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—RHOB—systemic scleroderma	9.92e-06	0.000376	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—IL1A—systemic scleroderma	9.89e-06	0.000375	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—HSPG2—systemic scleroderma	9.89e-06	0.000375	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—CD40LG—systemic scleroderma	9.83e-06	0.000373	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—IL1B—systemic scleroderma	9.83e-06	0.000373	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CSK—systemic scleroderma	9.66e-06	0.000366	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CSK—systemic scleroderma	9.55e-06	0.000362	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—EDN1—systemic scleroderma	9.45e-06	0.000358	CbGpPWpGaD
Caffeine—ADORA2A—GPCR ligand binding—CCL2—systemic scleroderma	9.43e-06	0.000358	CbGpPWpGaD
Caffeine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	9.39e-06	0.000356	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—HSPG2—systemic scleroderma	9.36e-06	0.000355	CbGpPWpGaD
Caffeine—PRKDC—Immune System—IL1B—systemic scleroderma	9.24e-06	0.00035	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—EDN1—systemic scleroderma	9.17e-06	0.000348	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—NOS3—systemic scleroderma	9.11e-06	0.000345	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—EDN1—systemic scleroderma	9.06e-06	0.000344	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CSK—systemic scleroderma	9.04e-06	0.000343	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	9.03e-06	0.000342	CbGpPWpGaD
Caffeine—PIK3CD—Hemostasis—TGFB1—systemic scleroderma	8.77e-06	0.000332	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—EDN1—systemic scleroderma	8.58e-06	0.000325	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—CCL2—systemic scleroderma	8.54e-06	0.000324	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—CTGF—systemic scleroderma	8.48e-06	0.000322	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	8.28e-06	0.000314	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—HLA-DQB1—systemic scleroderma	8.2e-06	0.000311	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—RHOB—systemic scleroderma	8.19e-06	0.000311	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—EDN1—systemic scleroderma	7.8e-06	0.000296	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IL1A—systemic scleroderma	7.79e-06	0.000295	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CD40LG—systemic scleroderma	7.75e-06	0.000294	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—HSPG2—systemic scleroderma	7.73e-06	0.000293	CbGpPWpGaD
Caffeine—PIK3CB—Hemostasis—TGFB1—systemic scleroderma	7.64e-06	0.00029	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—TGFB1—systemic scleroderma	7.64e-06	0.00029	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CSK—systemic scleroderma	7.46e-06	0.000283	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—CCL2—systemic scleroderma	7.44e-06	0.000282	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—EDN1—systemic scleroderma	7.38e-06	0.00028	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—CCL2—systemic scleroderma	7.37e-06	0.00028	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—EDN1—systemic scleroderma	7.08e-06	0.000268	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	6.84e-06	0.00026	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	6.74e-06	0.000255	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—HSPG2—systemic scleroderma	6.53e-06	0.000248	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—EDN1—systemic scleroderma	6.43e-06	0.000244	CbGpPWpGaD
Caffeine—PIK3CD—Disease—NOS3—systemic scleroderma	6.42e-06	0.000243	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—EDN1—systemic scleroderma	6.37e-06	0.000242	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	6.27e-06	0.000238	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—CCL2—systemic scleroderma	6.27e-06	0.000238	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—CCL2—systemic scleroderma	6.19e-06	0.000235	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—TGFB1—systemic scleroderma	6.02e-06	0.000228	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—IL1B—systemic scleroderma	5.92e-06	0.000224	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—HSPG2—systemic scleroderma	5.89e-06	0.000223	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—CCL2—systemic scleroderma	5.86e-06	0.000222	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	5.76e-06	0.000218	CbGpPWpGaD
Caffeine—PIK3CB—Disease—NOS3—systemic scleroderma	5.59e-06	0.000212	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—EDN1—systemic scleroderma	5.42e-06	0.000205	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—NOS3—systemic scleroderma	5.38e-06	0.000204	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—EDN1—systemic scleroderma	5.35e-06	0.000203	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—IL1B—systemic scleroderma	5.16e-06	0.000196	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	5.11e-06	0.000194	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—EDN1—systemic scleroderma	5.07e-06	0.000192	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CCL2—systemic scleroderma	5.04e-06	0.000191	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—CTGF—systemic scleroderma	4.95e-06	0.000188	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—CCL2—systemic scleroderma	4.84e-06	0.000184	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—NOS3—systemic scleroderma	4.69e-06	0.000178	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—NOS3—systemic scleroderma	4.5e-06	0.00017	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—CTGF—systemic scleroderma	4.46e-06	0.000169	CbGpPWpGaD
Caffeine—PIK3CA—Disease—NOS3—systemic scleroderma	4.41e-06	0.000167	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CCL2—systemic scleroderma	4.4e-06	0.000167	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	4.36e-06	0.000165	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CCL2—systemic scleroderma	4.36e-06	0.000165	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—HSPG2—systemic scleroderma	4.27e-06	0.000162	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—HSPG2—systemic scleroderma	4.26e-06	0.000161	CbGpPWpGaD
Caffeine—PIK3CD—Disease—TGFB1—systemic scleroderma	4.24e-06	0.000161	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—EDN1—systemic scleroderma	4.18e-06	0.000159	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IL1B—systemic scleroderma	4.06e-06	0.000154	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—HSPG2—systemic scleroderma	4.02e-06	0.000152	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—NOS3—systemic scleroderma	3.92e-06	0.000149	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—NOS3—systemic scleroderma	3.88e-06	0.000147	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	3.77e-06	0.000143	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CCL2—systemic scleroderma	3.7e-06	0.00014	CbGpPWpGaD
Caffeine—PIK3CB—Disease—TGFB1—systemic scleroderma	3.7e-06	0.00014	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—NOS3—systemic scleroderma	3.69e-06	0.00014	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—HSPG2—systemic scleroderma	3.69e-06	0.00014	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CCL2—systemic scleroderma	3.66e-06	0.000139	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—MMP9—systemic scleroderma	3.61e-06	0.000137	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CCL2—systemic scleroderma	3.46e-06	0.000131	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—NOS3—systemic scleroderma	3.3e-06	0.000125	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—NOS3—systemic scleroderma	3.26e-06	0.000124	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—CTGF—systemic scleroderma	3.23e-06	0.000123	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—CTGF—systemic scleroderma	3.23e-06	0.000122	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—HSPG2—systemic scleroderma	3.21e-06	0.000122	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—MMP9—systemic scleroderma	3.14e-06	0.000119	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—MMP9—systemic scleroderma	3.11e-06	0.000118	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—NOS3—systemic scleroderma	3.09e-06	0.000117	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—CTGF—systemic scleroderma	3.05e-06	0.000116	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—HSPG2—systemic scleroderma	3.03e-06	0.000115	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—HSPG2—systemic scleroderma	3e-06	0.000114	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TGFB1—systemic scleroderma	2.97e-06	0.000113	CbGpPWpGaD
Caffeine—PIK3CA—Disease—TGFB1—systemic scleroderma	2.92e-06	0.000111	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCL2—systemic scleroderma	2.86e-06	0.000108	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CTGF—systemic scleroderma	2.79e-06	0.000106	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MMP9—systemic scleroderma	2.65e-06	0.0001	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MMP9—systemic scleroderma	2.62e-06	9.92e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TGFB1—systemic scleroderma	2.59e-06	9.82e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TGFB1—systemic scleroderma	2.57e-06	9.73e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—HSPG2—systemic scleroderma	2.56e-06	9.72e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NOS3—systemic scleroderma	2.55e-06	9.66e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MMP9—systemic scleroderma	2.48e-06	9.39e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CTGF—systemic scleroderma	2.43e-06	9.23e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CTGF—systemic scleroderma	2.29e-06	8.7e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CTGF—systemic scleroderma	2.27e-06	8.62e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TGFB1—systemic scleroderma	2.18e-06	8.28e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TGFB1—systemic scleroderma	2.16e-06	8.18e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—NOS3—systemic scleroderma	2.15e-06	8.17e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MMP9—systemic scleroderma	2.04e-06	7.75e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TGFB1—systemic scleroderma	2.04e-06	7.74e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—HSPG2—systemic scleroderma	1.98e-06	7.5e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CTGF—systemic scleroderma	1.94e-06	7.37e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—NOS3—systemic scleroderma	1.94e-06	7.37e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TGFB1—systemic scleroderma	1.69e-06	6.39e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CTGF—systemic scleroderma	1.5e-06	5.69e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—NOS3—systemic scleroderma	1.41e-06	5.34e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—NOS3—systemic scleroderma	1.4e-06	5.32e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—NOS3—systemic scleroderma	1.33e-06	5.03e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—NOS3—systemic scleroderma	1.22e-06	4.61e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—NOS3—systemic scleroderma	1.06e-06	4.02e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—NOS3—systemic scleroderma	9.99e-07	3.79e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—NOS3—systemic scleroderma	9.9e-07	3.75e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—NOS3—systemic scleroderma	8.46e-07	3.21e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NOS3—systemic scleroderma	6.53e-07	2.48e-05	CbGpPWpGaD
